复杂主动脉瘤:去分支技术仍是当前适应证
胸腹主动脉瘤开放修复术并发症严重,即刻死亡率可达20%。本文报道一例多次手术史、广泛主动脉瘤合并肾内脏段慢性包裹性破裂的患者,因解剖条件不适合纯腔内治疗,成功采用肾内脏去分支杂交技术。
要点
- 胸腹主动脉瘤开放修复即刻死亡率可高达20%。
- 肾内脏去分支仍是高危或解剖不适合腔内患者的选择。
- 解剖条件限制时杂交技术可作为替代方案。
核心结论
- 肾内脏去分支杂交技术仍是高危开放手术患者及解剖不适合腔内治疗患者的有效替代方案。
研究设计与样本
- 单病例报告,描述一例多次手术史、广泛主动脉瘤合并肾内脏段慢性包裹性破裂的患者。
主要发现
- 该患者因解剖标准排除纯腔内管理后,成功接受肾内脏去分支杂交技术治疗。
关键数值与推荐
- 胸腹主动脉瘤传统开放修复即刻死亡率可达20%。
临床怎么用
- 对于高危开放手术且解剖不适合腔内治疗的胸腹主动脉瘤患者,可考虑肾内脏去分支杂交技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Conventional open repair of thoracoabdominal aortic aneurysms is still associated with severe complications and shows immediate mortality rates up to 20%. Although there is an increasing number of cases treated exclusively by an endovascular approach, renovisceral debranching still represents a valid alternative in high-risk patients for open surgery and in those patients where endovascular procedures are not feasible due to anatomic limitations or are not available when patients cannot wait for treatment. Herein we report the case of a patient with multiple surgical interventions and an extensive aortic aneurysm, complicated with a chronic contained rupture of the renovisceral aorta, who was successfully treated by means of a hybrid technique involving renovisceral debranching after discarding a pure endovascular management due to anatomical criteria.
引用
- Padrón Encalada C, Fernandez Prendes C, Rivas Dominguez M, et al. Complex Aortic Aneurysm: A Current Indication for Debranching. Ann Vasc Surg. 2017. PMID: 28242405. doi:10.1016/j.avsg.2016.09.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。